Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Diabetes Res Clin Pract. 2020 Nov 24;171:108555. doi: 10.1016/j.diabres.2020.108555

Table 2:

Proportion achieving guideline-recommended glycemic level (HbA1C<7.0%) at 12-month, 24 month and End of study (EOS) visit and factors associated with achievement of guideline-recommended glycemic control

Factors Glycaemic level (HbA1c<7.0%) Crude RR
[95% CI]
Adjusted RR^
[95% CI]
12m 24m EOS Overall
Overall 14.7[12.6,16.9] 17.5[14.5,20.5] 17.7[15.4,20] 16.3[14.6,18.1]
Age, years
35-49 13.7[10.5,16.9] 16.2[12.1,20.4] 16.4[12.7,20.1] 15.2[12,18.5] 1.00 1.00
50-64 15.5[12.8,18.1] 18.4[14.8,21.9] 18.5[15.7,21.4] 17.3[14.9,19.6] 1.13[0.88,1.46] 1.32[1.02,1.71]*
≥65 14[10.2,17.9] 16.6[11.6,21.7] 16.8[12.1,21.5] 15.6[11.5,19.8] 1.03[0.73,1.44] 1.28[0.89,1.86]
Gender
Female 13.6[11.1,16.1] 16.1[12.8,19.4] 16.3[13.5,19] 15.1[12.8,17.5] 1.00 1.00
Male 16.1[13.2,18.9] 19.1[15.3,22.9] 19.3[16.1,22.5] 17.9[15.3,20.6] 1.18[0.96,1.47] 1.17[0.93,1.47]
Socio-economic status
<10,000 14.5[10.7,18.3] 16.9[12.2,21.6] 17.1[12.9,21.4] 16[12.2,19.8] 1.00 1.00
10,000-20,000 14.7[10.7,18.7] 17.1[12.2,22.1] 17.4[12.6,22.1] 16.2[12.1,20.4] 1.01[0.72,1.44] 0.98[0.7,1.36]
>20,000 15[11.8,18.2] 17.6[13.5,21.6] 17.8[14.2,21.4] 16.6[13.5,19.7] 1.04[0.74,1.46] 0.93[0.68,1.28]
Education Status
Up to primary school 12.7[9.4,16] 15.2[11.1,19.2] 15.1[11.2,19] 14.1[10.7,17.5] 1.00 1.00
Secondary school 14.8[12,17.6] 17.7[13.9,21.5] 17.6[14.5,20.8] 16.5[13.8,19.2] 1.17[0.88,1.55] 1.12[0.83,1.51]
Graduate or above 16.5[12.9,20.1] 19.7[15,24.5] 19.7[15.6,23.7] 18.4[14.8,21.9] 1.3[0.94,1.81] 1.23[0.86,1.76]
Duration of Diabetes
5 years or less 20.6[17,24.2] 24.5[19.7,29.3] 24.5[20.5,28.5] 22.9[19.6,26.3] 1.00 1.00
6-10 years 12.2[9.2,15.3] 14.5[10.7,18.4] 14.5[11.1,18] 13.6[10.5,16.7] 0.59[0.45,0.78]** 0.63[0.47,0.83]**
11-15 years 9.9[6.8,13.1] 11.8[7.8,15.8] 11.8[8.1,15.5] 11[7.7,14.4] 0.48[0.34,0.68]** 0.56[0.39,0.8]**
>15 years 11.8[7.8,15.8] 11.8[8.1,15.5] 10[6.7,13.2] 11.1[7.6,14.6] 0.48[0.34,0.68]** 0.47[0.32,0.69]**
Any Macro vascular complication
No 14.8[12.6,17] 17.6[14.6,20.7] 17.8[15.4,20.1] 16.5[14.7,18.4] 1.00 1.00
Yes 13.4[6.9,20] 16[8,23.9] 16.1[8.4,23.8] 15 [7.8,22.1] 0.91[0.55,1.48] 1.09[0.68,1.76]
Any Micro vascular complication
No 16.8[14.1,19.6] 20[16.1,23.8] 20.1[17,23.1] 18.7[16.2,21.2] 1.00 1.00
Yes 11.1[8.5,13.7] 13.2[9.8,16.6] 13.3[10.2,16.3] 12.4[9.7,15.1] 0.66[0.51,0.86]** 0.70[0.53,0.92]*
Adherence to Prescribed Medication Therapy*
Non-Adherent 9.8[7.1,12.4] 11.8[8.4,15.1] 11.9[8.7,15] 11[8.2,13.8] 1.00 1.00
Adherent 15.8[13.4,18.1] 19[15.7,22.4] 19.2[16.6,21.8] 17.8[15.8,19.7] 1.62[1.24,2.11]** 1.46[1.09,1.95]*
Adherence to Diet Plan*
Non-Adherent 11[9.1,13] 13.3[10.6,16] 12.4[10,14.7] 12[10.1,13.9] 1.00 1.00
Adherent 21.6[17.7,25.5] 26[20.9,31.1] 24.2[20.6,27.7] 23.5[20.2,26.7] 1.96[1.59,2.41]** 1.79[1.43,2.23]**
Adherence to Exercise plan*
Non-Adherent 13.3[11.2,15.4] 15.9[12.9,18.9] 15.2[12.7,17.8] 14.6[12.6,16.6] 1.00 1.00
Adherent 17.7[14.5,20.9] 21.1[17.1,25.1] 20.2[17.3,23.2] 19.4[16.7,22] 1.33[1.12,1.57]** 1.06[0.87,1.3]
Hypertension (SBP >140 mmHg) at baseline
≤ 140 15.4[13.1,17.8] 18.3[15.1,21.6] 18.1[15.6,20.6] 17.1[15.1,19] 1.00 1.00
>140 12.4[9.1,15.7] 14.7[10.5,18.9] 14.6[10.7,18.4] 13.7[10.3,17.1] 0.8[0.61,1.05] 0.86[0.65,1.12]
Hyperlipidemia (LDL > 130 mg/dl) at baseline
≤ 130 15.3[13,17.6] 18[14.8,21.2] 18.1[15.6,20.5] 16.9[15,18.8] 1.00 1.00
>130 11.6[8.2,15.1] 13.6[9.4,17.9] 13.7[9.6,17.8] 12.8[9.2,16.5] 0.76[0.56,1.02] 0.82[0.6,1.14]
BMI
<25 14.2[11.2,17.2] 16.8[12.7,20.9] 17[13.5,20.4] 15.8[12.8,18.8] 1.00 1.00
25-29.9 16.1[13.2,19] 19.1[15.3,22.8] 19.3[16,22.5] 17.9[15.3,20.6] 1.14[0.9,1.44] 1.19[0.93,1.53]
≥ 30 13.6[10.5,16.7] 16.1[12.1,20] 16.2[12.7,19.8] 15.1[12,18.2] 0.96[0.72,1.27] 1.08[0.79,1.47]
Waist Circumference
Males <90 cm, Female <80 cm 13.4[9.5,17.4] 16[11.1,20.9] 16.1[11.5,20.6] 15[10.9,19.1] 1.00 1.00
Males >90cm, Females >80 cm 15[12.8,17.3] 17.9[14.7,21.1] 18[15.5,20.4] 16.8[14.8,18.7] 1.12[0.84,1.5] 1.33[0.95,1.85]
Smoking Status-baseline
No 14.6[12.4,16.7] 17.3[14.2,20.4] 17.5[15.2,19.8] 16.3[14.5,18] 1.00 1.00
Yes 18.2[10.3,26.1] 21.6[12.4,30.8] 21.8[12.6,31.1] 20.3[11.8,28.7] 1.25[0.81,1.91] 0.93[0.57,1.53]
Hospital setting
Public 1.00
Private 0.6[0.36,1]
*

P value <0.05

**

P value <0.005

^

Adjusted RR obtained via Poisson model using generalized estimating equation. Each estimate is adjusted for time, treatment assignment, baseline HbA1C value, site, public private settings and all other factors reported in table